Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in mult...
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis
About this item
Full title
Author / Creator
van den Elskamp, IJ , Knol, DL , Vrenken, H. , Karas, G. , Meijerman, A. , Filippi, M. , Kappos, L. , Fazekas, F. , Wagner, K. , Pohl, C. , Sandbrink, R. , Polman, CH , Uitdehaag, BMJ and Barkhof, F.
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Magnetization transfer ratio (MTR) is a sensitive parameter to quantify the integrity of myelinated white matter in patients with multiple sclerosis. Lesional MTR decreases in the acute phase due to demyelination, and subsequently shows recovery depending on the degree of remyelination in the absence of axonal loss. Recovery of average lesion MTR t...
Alternative Titles
Full title
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_755132276
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_755132276
Other Identifiers
ISSN
1352-4585
E-ISSN
1477-0970
DOI
10.1177/1352458510364630
